Menu
Unleashing the Power of Genomics to Improve Pet Health
PetDx™ is a team of veterinarians, scientists, and business leaders dedicated to revolutionizing the early detection of cancer in pets. We develop noninvasive cancer testing solutions that incorporate many of the latest advances from the human liquid biopsy space.
About Us
PetDx – The Liquid Biopsy Company for Pets™ is a San Diego-based molecular diagnostics company dedicated to unleashing the power of genomics to improve pet health. The company’s flagship product, OncoK9™, enables veterinarians to detect cancer in dogs with a simple blood draw. As a first-in-class multi-cancer early detection (MCED) test, OncoK9 employs cutting-edge genomic analysis that leverages next-generation sequencing (NGS) technology and proprietary bioinformatics algorithms empowering veterinarians to provide superior care to canine patients.
Executive Team
Board of Directors
Want to join the PetDx Pack? We are hiring.
Browse our open positions and submit your application.
Clinical Advisory Board
Advisors
Partners
Laboratory
PetDx performs high-complexity molecular diagnostic testing at its state-of-the-art laboratory in the Center for Novel Therapeutics at the University of California San Diego's Science Research Park.
Join the Revolution in Early Cancer Detection for Dogs
If you are eager to incoporate breakthrough innovation into your veterinary practice, we would love to partner with you. Be among the first to offer our pioneering multi-cancer early detection test to your canine patients. Provide your name and email address and we will reach out as we expand our rollout.